TELA Bio, Inc. (TELA)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about TELA Bio, Inc. (TELA)
Company Performance

Current Price

as of Oct 16, 2024

$2.60

P/E Ratio

N/A

Market Cap

$64.26M

Description

TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.

Metrics

Overview

  • HQMalvern, PA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerTELA
  • Price$2.6+2.36%

Trading Information

  • Market Cap$64.26M
  • Float67.40%
  • Average Daily Volume (1m)66,572
  • Average Daily Volume (3m)169,926
  • EPS-$1.72

Company

  • Revenue$64.74M
  • Rev Growth (1yr)11.02%
  • Net Income-$12.60M
  • Gross Margin68.81%
  • EBITDA Margin-70.36%
  • EBITDA-$11.32M
  • EV$130.81M
  • EV/Revenue2.02
  • P/EN/A
  • P/S0.99
  • P/B22.35
Documents
SEC Filings
8-K (2024-08-12)
8-K (2024-06-06)
8-K (2024-05-20)
8-K (2024-05-09)
8-K (2024-04-15)
8-K (2024-03-21)
8-K (2024-03-20)
8-K (2023-11-09)
8-K (2023-10-20)
8-K (2023-09-28)
8-K (2023-08-16)
8-K (2023-08-09)
8-K (2023-06-02)
8-K (2023-05-11)
8-K (2023-04-20)
8-K (2023-04-18)
8-K (2023-03-23)
8-K (2023-03-21)
8-K (2023-02-21)
8-K (2023-01-10)
8-K (2023-01-09)
10-Q (2024-08-13)
10-Q (2024-05-10)
10-Q (2023-11-13)
10-Q (2023-08-10)
10-Q (2023-05-11)
10-K (2024-03-22)
10-K (2023-03-23)
Earnings Calls
Earnings Report 2024Q2
Earnings Report 2024Q1
Earnings Report 2023Q4
Earnings Report (2023-11-12)
Earnings Report (2023-08-09)
Factset
Factset Business Description
Factset Street Account
TELA Bio reports Q3 EPS ($0.45) vs FactSet ($0.48) [5 est, ($0.59)-(0.43)] ($5.73, 0.00) (2023-11-09T21:34:22Z)
StreetAccount Earnings Call Q&A Summary: TELA Bio Q3 (2023-11-10T09:53:27Z)